Nilamkumar Patel
Clinical Cardiac Electrophysiology · Knoxville, TNNPI 1376664672
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,964 of the $17,264 with a category attached, or 69.3%. 45 manufacturers reported payments, led by Boston Scientific at 29.0% of the total. Reporting peaked in 2024 at $5,342 and has fallen 73.1% since, to $1,435 in 2025.
Across 512 payments — averaging $33.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Abbott$3K
- Medtronic$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Novartis$962
- Actelion Pharmaceuticals US, Inc.$511
- plus $5K from 39 others
Across 1 payment — averaging $385.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$385
What the payments were for
- Consulting fees$7504%
- Travel & lodging$4,55026%
- Food & beverage$11,96469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,178
- Watchman$1,122
- Micra$936
- Accent Pacemaker$750
- HeartMate$173
- Amplia MRI$162
- Barostim Neo System$141
- Impella$141
- Carto 3$137
- WATCHMAN FLX$131
- NAVITOR$121
- RESONATE$115
- RHYTHMIA$109
- ENTRESTO$103
How this compares
$17,264 in reported general payments places this provider in the 55th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 143 | $112,276 |
| XareltoRivaroxaban | 81 | $59,274 |
| MultaqDronedarone Hcl | 24 | $26,597 |
| EntrestoSacubitril/Valsartan | 19 | $12,589 |
| Dofetilide | 74 | $8,758 |
| Flecainide Acetate | 107 | $4,297 |
| Metoprolol Succinate | 162 | $1,903 |
| SotalolSotalol Hcl | 126 | $1,833 |
| Amiodarone Hcl | 32 | $511 |
| Pantoprazole Sodium | 74 | $413 |
| Sucralfate | 70 | $409 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 25 | $250 |
| Digoxin | 13 | $220 |
| Carvedilol | 33 | $216 |
| ClopidogrelClopidogrel Bisulfate | 14 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $407 | $112,276143 claims |
| Johnson & JohnsonXarelto | $510 | $59,27481 claims |
| Sanofi-aventis U.S. LLCMultaq | $164 | $26,59724 claims |
| NovartisEntresto | $962 | $12,58919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Knoxville
- Jeffrey HirshKnoxville$36K
- Michael BaileyKnoxville$27K
- Elliott GoodwinKnoxville$26K
- William MahlowKnoxville$21K
- James CoxKnoxville$21K
- Thomas WannenburgKnoxville$8K
- William LindsayKnoxville$4K
- Hitesh MehtaKnoxville$4K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.